Market Challenges And Opportunities

High prevalence of chronic diseases such as cardiovascular disease, cancer, diabetes, and respiratory diseases would lead to increasing adoption of preventive healthcare products made from cordyceps sinensis extracts, which in turn would aid in growth of the cordyceps sinensis extract market. According to World Health Organizations statistics, in 2018, non-communicable diseases are responsible for over 41 million deaths, annually, which is equivalent to 71% of all deaths, worldwide. Furthermore, according to the same source cardiovascular diseases causes over 17.9 million deaths annually, followed by cancer (9.0 million), respiratory diseases (3.9million), and diabetes (1.6 million), respectively.

High prevalence of autoimmune and stress related disorders across the world, especially in developed regions such as North America and Europe. According to American Autoimmune Related Disease Association, more than 50 million people in the U.S. were affected by autoimmune disease in 2017. This would be another major factor driving growth of the cordyceps sinensis extract market. Increased preference for natural remedy for correcting chronic disease is new trend in world including U.S.

However, high cost of cordyceps sinensis extracts is expected to be a major factor deterring the market growth. Insufficient clinical evidence for many diseases such as cancer and diabetes may limit market growth for cordyceps sinensis extract. Furthermore, it is difficult to scale up the artificial cultivation of cordyceps sinensis species. High cost of cordyceps sinensis in the international market often leads to malpractice of adulteration and substitution in the extracts.